bay 59-3074 bay 59-3074 bay 59-3074 is a drug which is a cannabinoid receptor partial agonist developed by bayer ag. it has analgesic effects and is used in scientific research. it is orally active in animals, and has modest affinity for both cb1 and cb2 receptors, with ki values of 48.3nm at cb1 and 45.5nm at cb2. bay 59-3074legal statuslegal status in general: unscheduled identifiers iupac name 3-phenyl 4,4,4-trifluoro-1-butanesulfonic acid ester cas number406205-74-1 ypubchem cid10479060chemspider8654468 yunii5fo5z101guchemical and physical dataformulac18h13f6no4smolar mass453.36 g·mol−13d model (jsmol)interactive image smiles fc(f)(f)cccs(=o)(=o)oc2cc(oc1cccc(c1c#n)c(f)(f)f)ccc2 inchi inchi=1s/c18h13f6no4s/c19-17(20,21)8-3-9-30(26,27)29-13-5-1-4-12(10-13)28-16-7-2-6-15(14(16)11-25)18(22,23)24/h1-2,4-7,10h,3,8-9h2 ykey:lwuszivdpjpvbw-uhfffaoysa-n y (verify)